0001209191-16-103477.txt : 20160229
0001209191-16-103477.hdr.sgml : 20160229
20160229172911
ACCESSION NUMBER: 0001209191-16-103477
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160225
FILED AS OF DATE: 20160229
DATE AS OF CHANGE: 20160229
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TENET HEALTHCARE CORP
CENTRAL INDEX KEY: 0000070318
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC [8062]
IRS NUMBER: 952557091
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1445 ROSS AVENUE
STREET 2: SUITE 1400
CITY: DALLAS
STATE: TX
ZIP: 75202
BUSINESS PHONE: 469-893-2200
MAIL ADDRESS:
STREET 1: 1445 ROSS AVENUE
STREET 2: SUITE 1400
CITY: DALLAS
STATE: TX
ZIP: 75202
FORMER COMPANY:
FORMER CONFORMED NAME: NATIONAL MEDICAL ENTERPRISES INC /NV/
DATE OF NAME CHANGE: 19920703
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Andrews Audrey T.
CENTRAL INDEX KEY: 0001568933
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-07293
FILM NUMBER: 161469818
MAIL ADDRESS:
STREET 1: 1445 ROSS AVENUE
STREET 2: SUITE 1400
CITY: DALLAS
STATE: TX
ZIP: 75202
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2016-02-25
0
0000070318
TENET HEALTHCARE CORP
THC
0001568933
Andrews Audrey T.
1445 ROSS AVENUE
SUITE 1400
DALLAS
TX
75202
0
1
0
0
SVP and General Counsel
Common Stock
2016-02-25
4
M
0
4748
A
12497
D
Common Stock
2016-02-25
4
F
0
1367
24.81
D
11130
D
Common Stock
2016-02-25
4
M
0
7820
A
18950
D
Common Stock
2016-02-25
4
F
0
2136
24.81
D
16814
D
Common Stock
2016-02-26
4
M
0
3383
A
20197
D
Common Stock
2016-02-26
4
F
0
926
25.68
D
19271
D
Common Stock
2016-02-26
4
M
0
6766
A
26037
D
Common Stock
2016-02-26
4
F
0
1851
25.68
D
24186
D
Common Stock
2016-02-26
4
M
0
3392
A
27578
D
Common Stock
2016-02-26
4
F
0
928
25.68
D
26650
D
Common Stock
2016-02-26
4
M
0
3392
A
30042
D
Common Stock
2016-02-26
4
F
0
928
25.68
D
29114
D
2015 February Restricted Stock Units
2016-02-25
4
M
0
4748
0.00
D
Common Stock
4748
9498
D
2015 February Performance-Based Restricted Stock Units
2016-02-25
4
M
0
7820
0.00
D
Common Stock
7820
15644
D
2014 February Restricted Stock Units
2016-02-26
4
M
0
3383
0.00
D
Common Stock
3383
3383
D
2014 February Performance-Based Restricted Stock Units
2016-02-26
4
M
0
6766
0.00
D
Common Stock
6766
6766
D
2013 February Restricted Stock Units
2016-02-26
4
M
0
3392
0.00
D
Common Stock
3392
0
D
2013 February Performance-Based Restricted Stock Units
2016-02-26
4
M
0
3392
0.00
D
Common Stock
3392
0
D
As previously reported, on February 25, 2015, the reporting person received a grant of 14,245 time-based restricted stock units that vest in one-third increments on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on February 25, 2016, resulting in the vesting and settlement of 4,748 shares of common stock, as shown in Table I. The remaining 9,497 restricted stock units are shown in Table II, of which 4,748 are scheduled to vest on February 25, 2017 and 4,749 are scheduled to vest on February 25, 2018.
Restricted stock units convert into common stock on a one-for-one basis.
Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3.
As previously reported, on February 25, 2015, the reporting person received a target grant of 14,245 performance-based restricted stock units that were subject to the Company's attainment of a specified one-year performance metric for the year then-ending December 31, 2015. The actual number of stock units that could vest ranged from 0% to 200% of the target unit amount. The performance metric was exceeded and 164.7% of the target grant was awarded; therefore, these restricted stock units vest in one-third increments on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on February 25, 2016, resulting in the vesting and settlement of 7,820 shares of common stock, as shown in Table I. The remaining 15,644 performance restricted stock units are shown in Table II, of which 7,822 are scheduled to vest on each of February 25, 2017 and February 25, 2018.
As previously reported, on February 26, 2014, the reporting person received a grant of 10,149 time-based restricted stock units that vest in one-third increments on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on February 26, 2015, resulting in the vesting and settlement of 3,383 shares of common stock. The second anniversary occurred on February 26, 2016, resulting in the vesting and settlement of 3,383 shares of common stock, as shown in Table I. The remaining 3,383 restricted stock units are shown in Table II, which are scheduled to vest on February 26, 2017.
As previously reported, on February 26, 2014, the reporting person received a target grant of 10,149 performance-based restricted stock units that were subject to the Company's attainment of a specified one-year performance metric for the year then-ending December 31, 2014. The actual number of stock units that could vest ranged from 0% to 200% of the target unit amount. The performance metric was exceeded and 200% of the target grant was awarded; therefore, these restricted stock units vest in one-third increments on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on February 26, 2015, resulting in the vesting and settlement of 6,766 shares of common stock. The second anniversary occurred on February 26, 2016, resulting in the vesting and settlement of 6,766 shares of common stock, as shown in Table I. The remaining 6,766 performance restricted stock units are shown in Table II, which are scheduled to vest on February 26, 2017.
As previously reported, on February 28, 2013, the reporting person received a grant of 10,176 time-based restricted stock units that vest in one-third increments on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on February 28, 2014, resulting in the vesting and settlement of 3,392 shares of common stock. The second vesting date occurred on February 27, 2015 (the business day prior to the anniversary date, which fell on a weekend), resulting in the vesting and settlement of 3,392 shares of common stock. The third vesting date occurred on February 26, 2016 (the business day prior to the anniversary date, which fell on a weekend), resulting in the vesting and settlement of 3,392 shares of common stock, as shown in Table I.
As previously reported, on February 28, 2013, the reporting person received a target grant of 10,176 performance-based restricted stock units that were subject to the Company's attainment of a specified one-year performance metric for the year then-ending December 31, 2013. The performance metric was met; therefore, these restricted stock units vest in one-third increments on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on February 28, 2014, resulting in the vesting and settlement of 3,392 shares of common stock. The second vesting date occurred on February 27, 2015 (the business day prior to the anniversary date, which fell on a weekend), resulting in the vesting and settlement of 3,392 shares of common stock. The third vesting date occurred on February 26, 2016 (the business day prior to the anniversary date which fell on a weekend), resulting in the vesting and settlement of 3,392 shares of common stock, as shown in Table I.
Both time-based restricted stock units and performance-based restricted stock units are settled in shares of the Company's common stock upon vesting.
Anthony L. Shoemaker, as Attorney-in-Fact for Audrey T. Andrews
2016-02-29